Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
9.98
-0.01 (-0.10%)
At close: Mar 6, 2026, 4:00 PM EST
10.00
+0.02 (0.20%)
After-hours: Mar 6, 2026, 7:57 PM EST
Novavax Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 1,123 | 682.16 | 983.71 | 1,982 | 1,146 | Upgrade
|
| Revenue Growth (YoY) | 64.69% | -30.65% | -50.37% | 72.89% | 141.02% | Upgrade
|
| Cost of Revenue | 395.79 | 569.64 | 1,037 | 2,071 | 2,535 | Upgrade
|
| Gross Profit | 727.69 | 112.52 | -53.55 | -89.48 | -1,388 | Upgrade
|
| Selling, General & Admin | 150.38 | 323.59 | 457.45 | 488.69 | 298.36 | Upgrade
|
| Research & Development | 14.07 | 20.87 | 41.21 | 66.57 | - | Upgrade
|
| Operating Expenses | 164.45 | 344.45 | 498.66 | 555.26 | 298.36 | Upgrade
|
| Operating Income | 563.24 | -231.93 | -552.21 | -644.74 | -1,687 | Upgrade
|
| Interest Expense | -22.55 | -20.08 | -14.42 | -19.88 | -21.13 | Upgrade
|
| Currency Exchange Gain (Loss) | -16.7 | -4.4 | 7.9 | -2.5 | -5.3 | Upgrade
|
| Other Non Operating Income (Expenses) | 57.33 | 44.84 | 30 | 13.47 | -1.53 | Upgrade
|
| EBT Excluding Unusual Items | 581.33 | -211.56 | -528.73 | -653.65 | -1,715 | Upgrade
|
| Merger & Restructuring Charges | -12.6 | -17 | -14.3 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -97.85 | 51.95 | - | - | - | Upgrade
|
| Other Unusual Items | -28.71 | - | - | - | - | Upgrade
|
| Pretax Income | 442.17 | -176.62 | -543.03 | -653.65 | -1,715 | Upgrade
|
| Income Tax Expense | 1.87 | 10.88 | 2.03 | 4.29 | 29.22 | Upgrade
|
| Net Income | 440.3 | -187.5 | -545.06 | -657.94 | -1,744 | Upgrade
|
| Net Income to Common | 440.3 | -187.5 | -545.06 | -657.94 | -1,744 | Upgrade
|
| Shares Outstanding (Basic) | 162 | 152 | 101 | 78 | 74 | Upgrade
|
| Shares Outstanding (Diluted) | 173 | 152 | 101 | 78 | 74 | Upgrade
|
| Shares Change (YoY) | 13.74% | 51.03% | 28.89% | 5.08% | 29.27% | Upgrade
|
| EPS (Basic) | 2.72 | -1.23 | -5.41 | -8.42 | -23.44 | Upgrade
|
| EPS (Diluted) | 2.58 | -1.23 | -5.41 | -8.42 | -23.44 | Upgrade
|
| Free Cash Flow | -250.2 | -100.32 | -767.74 | -504.99 | 268.45 | Upgrade
|
| Free Cash Flow Per Share | -1.45 | -0.66 | -7.62 | -6.46 | 3.61 | Upgrade
|
| Gross Margin | 64.77% | 16.50% | -5.44% | -4.52% | -121.10% | Upgrade
|
| Operating Margin | 50.13% | -34.00% | -56.14% | -32.53% | -147.13% | Upgrade
|
| Profit Margin | 39.19% | -27.49% | -55.41% | -33.20% | -152.12% | Upgrade
|
| Free Cash Flow Margin | -22.27% | -14.71% | -78.05% | -25.48% | 23.42% | Upgrade
|
| EBITDA | 590.85 | -183.44 | -510.99 | -615.68 | -1,674 | Upgrade
|
| EBITDA Margin | 52.59% | -26.89% | -51.94% | -31.07% | -146.03% | Upgrade
|
| D&A For EBITDA | 27.61 | 48.5 | 41.23 | 29.05 | 12.66 | Upgrade
|
| EBIT | 563.24 | -231.93 | -552.21 | -644.74 | -1,687 | Upgrade
|
| EBIT Margin | 50.13% | -34.00% | -56.14% | -32.53% | -147.13% | Upgrade
|
| Effective Tax Rate | 0.42% | - | - | - | - | Upgrade
|
| Revenue as Reported | 1,123 | 682.16 | 983.71 | 1,982 | 1,146 | Upgrade
|
| Advertising Expenses | 1.9 | 33.7 | 91.5 | 84 | 8.9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.